Stocks › EW
Edwards Lifesciences Corp
EW·NYSE·
United States·USD
United States·USD$85.78
-0.70 (-0.81%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
EW
Edwards Lifesciences Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EWS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EW by members of U.S. Congress · 115 on record · 9 in the last 12 months
Whale Activity
Position changes in EW reported for 2026-09-30 by 3 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| Weaver Consulting Group | 46.8K | $4.0M | — |
| Private Capital Advisors, Inc. | 12.3K | $1.1M | — |
| American National Bank of Texas | 3,010 | $260K | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EW insiders, by quarter · Form 4
Recent Insider Transactions
4,791 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $87.51 | $54K | Sep 11, 2026 | Form 4 ↗ |
| Dahl Andrew M.SVP, Corporate Controller | Sale | −544 | $91.06 | $50K | Aug 31, 2026 | Form 4 ↗ |
| Bruls AnnetteCVP, EMEACLA | Sale | −2,644 | $89.98 | $238K | Aug 28, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | −30.6K | $90.99 | $2.8M | Aug 26, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | −1,154 | $91.76 | $106K | Aug 26, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −1,240 | $91.47 | $113K | Aug 26, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $92.03 | $57K | Aug 11, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −146 | $86.03 | $13K | Jul 30, 2026 | Form 4 ↗ |
| Markowitz WayneCVP, JAPAC | Sale | −9,628 | $85.06 | $819K | Jul 28, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −2,921 | $83.93 | $245K | Jul 27, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $91.70 | $57K | Jul 10, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −619 | $91.40 | $57K | Jun 30, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Option exercise | +619 | $72.68 | $45K | Jun 30, 2026 | Form 4 ↗ |
| Zovighian Bernard JCEO · Director | Sale | −523 | $87.92 | $46K | Jun 17, 2026 | Form 4 ↗ |
| Dahl Andrew M.SVP, Corporate Controller | Sale | −568 | $86.08 | $49K | May 29, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −23.1K | $86.42 | $2.0M | May 27, 2026 | Form 4 ↗ |
| Chopra DaveenCVP, TMTT & Surgical | Sale | −1,500 | $84.60 | $127K | May 22, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Sale | −620 | $81.14 | $50K | May 18, 2026 | Form 4 ↗ |
| Lippis Daniel J.CVP, TAVR | Option exercise | +620 | $72.68 | $45K | May 18, 2026 | Form 4 ↗ |
| BOBO DONALD E JRCVP,Strategy/Corp Development | Sale | −8,000 | $81.82 | $655K | May 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EW · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 18.3M | $1.65B | 0.07% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 14.9M | $1.35B | 0.08% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 12.5M | $1.13B | 0.50% | Jun 30, 2026 |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 11.4M | $977.6M | 2.56% | Jul 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 7.9M | $716.5M | 0.08% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 7.4M | $642.1M | 0.08% | May 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 7.0M | $631.3M | 0.08% | Jun 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 5.5M | $495.3M | 0.19% | Jun 30, 2026 |
| VANGUARD MID-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 4.4M | $399.0M | 1.15% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 4.1M | $368.0M | 0.91% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list EW's shares (CUSIP 28176E108), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming edwards lifesciences as client
- EDWARDS LIFESCIENCES, LLCEDWARDS LIFESCIENCES LLC · 2026 Q2 · HCR, MMM, TRD$280K
Filing ↗ - BGR GOVERNMENT AFFAIRSEDWARDS LIFESCIENCES LLC · 2026 Q2 · HCR$50K
Filing ↗ - AVENUE SOLUTIONSEDWARDS LIFESCIENCES LLC · 2026 Q2 · MMM$50K
Filing ↗ - FARRAGUT PARTNERS LLPEDWARDS LIFESCIENCES, LLC · 2026 Q2 · HCR, MMM$50K
Filing ↗ - AKIN GUMP STRAUSS HAUER & FELDEDWARDS LIFESCIENCES LLC · 2026 Q2$60K
Filing ↗
Government Contracts
Federal awards to edwards lifesciences · USAspending
$11.3MAwarded · 217 contracts on record
- Department of Veterans AffairsPROSTHETICS EMERGENT HEART VALVE SURGICAL IMPLANT$16K
Nov 21, 2024 · ↗ - Department of Veterans AffairsEXPRESS REPORT: HEART VALVES$232K
Jul 1, 2026 · ↗ - Department of Veterans AffairsTRANSCATHETER HEART VALVE INVENTORY REPLACEMENT 29MM$34K
Oct 6, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: HEART VALVES$10K
Jul 1, 2026 · ↗ - Department of Veterans AffairsPROSTHETICS EMERGENCY HEART VALVE SURGICAL IMPLANTS$16K
Dec 9, 2025 · ↗ - Department of Veterans AffairsIMPLANT$34K
Oct 5, 2026 · ↗ - Department of Veterans AffairsHEART VALVE$68K
Oct 5, 2026 · ↗ - Department of Veterans AffairsPASCAL IMPLANT$36K
Oct 2, 2026 · ↗
U.S. Patents
Recent USPTO applications naming Edwards Lifesciences Corp
No USPTO patent applications found for Edwards Lifesciences Corp.
Annual Financials
From EW's 10-K filings · XBRL
No annual XBRL figures on record for EW. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 3-for-1Stock splitJun 1, 2020
- 2-for-1Stock splitDec 14, 2015
- 2-for-1Stock splitMay 28, 2010
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
About Edwards Lifesciences Corp
From SEC EDGAR company records
Industry (SIC 3842)Orthopedic, Prosthetic & Surgical Appliances & Supplies
SectorHealthcare
HeadquartersIRVINE, CA
IncorporatedDE
SEC CIK0001099800 ↗
Former namesCVG CONTROLLED INC